Caricamento...
Paradoxical response to osimertinib therapy in a patient with T790M-mutated lung adenocarcinoma
A ‘paradoxical response’ to cancer treatment is a term used to describe the emergence of unexpected new lesions and the progression of existing lesions, despite appropriate and effective therapy. ‘Pseudo-progression’ is a phenomenon in which lymphocytes activated by an immune checkpoint inhibitor ac...
Salvato in:
| Pubblicato in: | Mol Clin Oncol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5738702/ https://ncbi.nlm.nih.gov/pubmed/29285395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1474 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|